Deals & Corporate Governance
- 
									March 31, 2025
									Alcoa Retirees, Unions Win Block On Health Benefits CutoffAluminum producer Alcoa USA Corp. must provide lifetime healthcare benefits to a group of retirees who were represented by unions, an Indiana federal judge ruled, greenlighting an injunction that allows class members to retroactively seek payments for costs. 
- 
									March 31, 2025
									Pierson Ferdinand Adds Taylor English Health Pro In AtlantaPierson Ferdinand LLP announced Monday that it has hired a former Taylor English Duma LLP partner who specializes in mergers and acquisitions and also has sleep medicine expertise to strengthen its healthcare practice. 
- 
									March 28, 2025
									Taxation With Representation: Norton Rose, Latham, AshurstIn this week's Taxation With Representation, Dollar Tree sells its Family Dollar business to private equity firms, eye care company Alcon buys medical technology company Lensar and Ithaca Energy PLC buys the U.K. subsidiary of Japan Petroleum Exploration Co. Ltd. 
- 
									March 26, 2025
									Sotomayor Urges Caution On Nondelegation Doctrine RevampU.S. Supreme Court Justice Sonia Sotomayor cautioned her colleagues during oral arguments Wednesday against using a challenge to the Federal Communications Commission's administration of a broadband subsidy program as a way to resurrect the long-dormant nondelegation doctrine. Several conservative justices, however, seemed willing to disregard that admonition. 
- 
									March 26, 2025
									7 Firms Compete To Lead Novo Nordisk Securities SuitLevi & Korsinsky LLP, Pomerantz LLP and the Rosen Law Firm PA are among seven law firms vying to lead proposed class claims accusing Novo Nordisk A/S of misleading investors about a clinical trial for an obesity drug. 
- 
									March 26, 2025
									Ex-CEO Says McGuireWoods Can't Rehash Immunity AppealMcGuireWoods LLP and one of its former partners are rehashing immunity defenses in a last-ditch effort to dodge a long-running defamation case, the former CEO of a managed care organization told the North Carolina Court of Appeals in seeking to have the case kicked back down to the trial court. 
- 
									March 25, 2025
									Healthcare Deals This Week: Merck, J&J And Startups GaloreIt's been a busy week for healthcare. Several Big Pharma players inked licensing deals in areas like cardiology and cancer and others said they would up their U.S. manufacturing investments, continuing a growing trend for companies in the space. 
- 
									March 25, 2025
									Pension Seeks To Opt Class Out Of Cutera Ch. 11 ReleasesA pension fund heading up a class action against skin care technology group Cutera has urged a Texas bankruptcy court to find the shareholder has authority to opt all class members out of the company's Chapter 11 plan. 
- 
									March 25, 2025
									Crowell & Moring Healthcare Vet Jumps To Sheppard MullinA longtime Crowell & Moring LLP partner has moved his healthcare-focused practice to Sheppard Mullin Richter & Hampton LLP's office in Washington, D.C., the firm announced Tuesday. 
- 
									March 25, 2025
									Merck Betting Up To $2B On China-Developed Cardio DrugPharmaceutical giant Merck & Co. Inc., advised by Gibson Dunn & Crutcher LLP and Covington & Burling LLP, said on Tuesday it has entered into an exclusive license agreement with Cooley LLP-led pharmaceutical company Jiangsu Hengrui Pharmaceuticals Co. Ltd. under which Merck will pay up to nearly $2 billion to the Chinese pharmaceutical business. 
- 
									March 25, 2025
									Meitar-Led Navina Wraps $55M Series C Funding RoundArtificial intelligence-powered clinical intelligence company Navina, advised by Meitar, announced on Tuesday that it clinched a $55 million Series C funding round, bringing its total amount raised to $100 million. 
- 
									March 25, 2025
									4th Circ. Won't Rehear Drug Price-Fixing Class ActionThe Fourth Circuit said Tuesday it will not hold a full court rehearing of its panel decision to back the dismissal of a proposed class action accusing drugmakers of conspiring and inflating the price of a medication for Huntington's disease, a suit the panel called "shaky at best." 
- 
									March 24, 2025
									Kenvue, J&J Must Face Investor Suit Over FDA ConcernsConsumer health products business Kenvue Inc. and former parent company Johnson & Johnson cannot escape a consolidated lawsuit accusing the companies of failing to warn investors about the potential ineffectiveness of leading products like Tylenol and Sudafed ahead of Kenvue's initial public offering, a New Jersey federal judge ruled on Monday. 
- 
									March 24, 2025
									Fla. Judge OKs $19.3M In Spinal Products Noncompete SuitA Florida federal judge approved a $19.3 million judgment against the owner of a distributor and his affiliated companies, finding that he owes damages for breaching an exclusive sales agreement with a spinal products manufacturer in a case with a "tortured history" that lasted for more than six years. 
- 
									March 24, 2025
									Residents Rip Hospital Co.'s 'Scorched-Earth' Sanctions BidA proposed class of Connecticut residents pursuing antitrust claims against Hartford HealthCare Corp. slammed the company's bid to sanction them for seeking judicial enforcement of a document exchange deal the parties had reached, arguing that sanctions would only complicate discovery rather than help it along. 
- 
									March 24, 2025
									Norton Rose, Latham Steer Alcon's $430M Lensar BuyEye care company Alcon, advised by Norton Rose Fulbright, unveiled on Monday an agreement to purchase medical technology developer Lensar, which is represented by Latham & Watkins LLP, for up to $430 million. 
- 
									March 21, 2025
									Bausch & Lomb Says Amcor Must Pay For Botched BottlesA packaging company evaded quality controls to deliver defective plastic bottles that caused a slowdown in manufacturing at a Bausch & Lomb facility, the eye care company has claimed in a complaint filed in Michigan federal court. 
- 
									March 20, 2025
									Judge Won't Let Meijer Appeal Takeda's Arbitration MandateA Massachusetts federal judge refused Thursday to let Meijer immediately appeal his order letting Takeda Pharmaceutical force the grocery chain into arbitration and out of its role as a representative of a proposed class of direct purchasers suing over delayed generics to a constipation drug. 
- 
									March 20, 2025
									Medical Malpractice Insurers Ink $1.3B Merger DealPhysician-owned medical malpractice insurer The Doctors Company has agreed to acquire ProAssurance Corp. in a deal valued at approximately $1.3 billion, in what the company said will create a combined entity with approximately $12 billion in assets. 
- 
									March 20, 2025
									Minn. Bill Seeks Millionaire Tax To Offset Medicaid CutsMinnesota would create a new tax bracket for individual income above $1 million and set the tax rate at a level to offset estimated changes in federal Medicaid funding under legislation introduced Thursday in the state Senate. 
- 
									March 19, 2025
									AI Chatbot Co. LivePerson Beats Shareholder Suit For GoodA New York federal judge on Wednesday tossed for good a consolidated shareholder class action alleging that chatbot developer LivePerson Inc. misled investors about its post-COVID financial performance and the purported success of WildHealth, a health-focused company it acquired. 
- 
									March 19, 2025
									Sotera Beats Shareholder Suit Over Sterigenics EmissionsLife sciences company Sotera Health has beaten a shareholder suit alleging it made a series of false and misleading statements about its environmental controls and liability exposure from numerous lawsuits against subsidiary Sterigenics, with the court ruling the plaintiffs have not shown the company intended to deceive the public. 
- 
									March 19, 2025
									NC Captive Insurer's Owner Can't Shirk Self-Dealing ClaimsNorth Carolina's business court has largely rejected a majority shareholder's efforts to curtail claims he seized control of a captive insurance company only to run it into the ground, finding the suit sufficiently ties him to unpaid premiums that dried up the insurer's sole source of revenue. 
- 
									March 19, 2025
									Law360 Announces The Members Of Its 2025 Editorial BoardsLaw360 is pleased to announce the formation of its 2025 Editorial Advisory Boards. 
- 
									March 19, 2025
									Healthcare Consultant Says Tufts Medicine Owes $1MHospital operator Tufts Medicine has failed to pay more than $1 million in fees and commissions to healthcare consulting group Sellers Dorsey & Associates LLC, according to a lawsuit filed in Massachusetts state court. 
Expert Analysis
- 
								
								Merger Proposals Reflect Agency Leaders' Antitrust Principles  Attorneys at Covington trace the recently proposed Hart-Scott-Rodino and merger guidelines changes to certain foundational concerns of the Federal Trade Commission and U.S. Department of Justice Antitrust Division leadership, including issues related to concentration associated with horizontal and vertical mergers. 
- 
								
								The Basics Of Being A Knowledge Management AttorneyExcerpt from Practical Guidance.jpg)  Michael Lehet at Ogletree Deakins discusses the role of knowledge management attorneys at law firms, the common tasks they perform and practical tips for lawyers who may be considering becoming one. 
- 
								
								Challenging Standing In Antitrust Classes: The Uninjured  In virtually every antitrust class action, parties at the certification phase disagree about whether the proposed class includes uninjured members, but the goals of Rule 23 and judicial economy are best served by synthesizing two distinct approaches circuit courts take on this issue, say Michael Hamburger and Holly Tao at White & Case. 
- 
								
								What Big Tobacco's Cannabis Investments Mean For Market  The tobacco industry appears to be shoring up investments in the cannabis market, most recently with Philip Morris’ purchase of an Israeli cannabis tech company, pointing to a bright future for vaped and noncombustible products, and signaling that marijuana rescheduling may be on the horizon, say Slates Veazey and Whitt Steineker at Bradley Arant. 
- 
								
								To Hire And Keep Top Talent, Think Beyond Compensation  Firms seeking to appeal to sophisticated clients and top-level partners should promote mentorship, ensure that attorneys from diverse backgrounds feel valued, and clarify policies about at-home work, says Patrick Moya at Quaero Group. 
- 
								
								How Merger Review Overhaul Could Affect Health Industry  For those in the health care industry considering growth and expansion strategies, the antitrust agencies' recent proposals for new Hart-Scott-Rodino rules and more complex merger guidelines will increase deal timelines, the merging parties' burden, and overall uncertainty and potential antitrust risk as to the outcome, say attorneys at Husch Blackwell. 
- 
								
								More States Should Join Effort To Close Legal Services Gap  Colorado is the most recent state to allow other types of legal providers, not just attorneys, to offer specific services in certain circumstances — and more states should rethink the century-old assumptions that shape our current regulatory rules, say Natalie Anne Knowlton and Janet Drobinske at the University of Denver. 
- 
								
								Identifying Trends And Tips In Litigation Financing Disclosure  Growing interest and controversy in litigation financing raise several salient concerns, but exploring recent compelled disclosure trends from courts around the country can help practitioners further their clients' interests, say Sean Callagy and Samuel Sokolsky at Arnold & Porter. 
- 
								
								Bid Protest Spotlight: Personnel Loss, Conflicts, Timeliness  In this month's bid protest roundup, Locke Bell at MoFo highlights recent decisions from the U.S. Court of Federal Claims and the U.S. Government Accountability Office, addressing an offeror's loss of key personnel, organizational conflicts of interest arising out of reliance on former government employees in preparing a bid, and protest timeliness when no debriefing is required. 
- 
								
								Congress Needs Better Health Care Fraud Data From DOD  The U.S. Department of Defense does not collect enough data to prevent health care and service contractor fraud and waste, so Congress should enact benchmarks that the DOD must meet when gathering and reporting data, enabling lawmakers to make better-informed decisions about defense appropriations, says Jessica Lehman at Verizon. 
- 
								
								The Pop Culture Docket: Judge Elrod On 'Jury Duty'  Though the mockumentary series “Jury Duty” features purposely outrageous characters, it offers a solemn lesson about the simple but brilliant design of the right to trial by jury, with an unwitting protagonist who even John Adams may have welcomed as an impartial foreperson, says Fifth Circuit Judge Jennifer Elrod. 
- 
								
								4 Business-Building Strategies For Introvert AttorneysExcerpt from Practical Guidance  Introverted lawyers can build client bases to rival their extroverted peers’ by adapting time-tested strategies for business development that can work for any personality — such as claiming a niche, networking for maximum impact, drawing on existing contacts and more, says Ronald Levine at Herrick Feinstein. 
- 
								
								3 Ways Justices' Disclosure Defenses Miss The Ethical Point  The rule-bound interpretation of financial disclosures preferred by U.S. Supreme Court Justices Samuel Alito and Clarence Thomas — demonstrated in their respective statements defending their failure to disclose gifts from billionaires — show that they do not understand the ethical aspects of the public's concern, says Jim Moliterno at the Washington and Lee University School of Law.